NewAmsterdam Pharma Company
NAMS
#4227
Rank
A$3.19 B
Marketcap
$29.11
Share price
-0.92%
Change (1 day)
-11.40%
Change (1 year)

Revenue for NewAmsterdam Pharma Company (NAMS)

Revenue in 2024 (TTM): A$68.16 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's current revenue (TTM ) is A$72.82 Million. an increase over the revenue in the year 2023 that were of A$20.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NewAmsterdam Pharma Company from 2023 to 2024

Annual revenue

Year Revenue Change
2024 A$73.25 M254.2%
2023 A$20.68 M